HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Quantitative determination of biocytin in urine of patients with biotinidase deficiency using high-performance liquid chromatography (HPLC).

Abstract
A specific method for the quantitative determination of biocytin from urine of biotinidase deficient patients is described using HPLC-separation and quantitative determination by an avidin binding method. Partial purification of biocytin from urine was achieved with an anion exchange resin and concentration of the eluate by lyophilization. The recovery of biocytin from urines was 95.3 +/- 5.9 (mean +/- SD). The precision of biocytin estimation in patients urines including the HPLC-sample preparation procedure varied between 5.9% and 10.5% (CV). Biocytin concentrations were measured in urine samples of 5 patients obtained during and/or before biotin therapy. Before treatment biocytin excretion ranged from 6.2-28.8 nmol/mmol creatinine. During therapy biocytin excretion increased to the 1.3 to 4-fold level in 3 out of 4 patients. However, there was no dose-related increase of biocytin excretion when pharmacological doses were administered. Apart from biocytin and biotin, patients excrete additional biotin derivatives. Some of these have been preliminary identified as bisnorbiotin and oxidation products of bisnorbiotin, biocytin and biotin.
AuthorsT M Suormala, E R Baumgartner, J Bausch, W Holick, H Wick
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 177 Issue 3 Pg. 253-69 (Oct 31 1988) ISSN: 0009-8981 [Print] Netherlands
PMID3148376 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biotin
  • Amidohydrolases
  • Biotinidase
  • biocytin
  • Lysine
Topics
  • Amidohydrolases (deficiency)
  • Biotin (analogs & derivatives)
  • Biotinidase
  • Chromatography, High Pressure Liquid
  • Europe
  • Humans
  • Lysine (analogs & derivatives, urine)
  • Reference Standards

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: